We are live on
!
Find out more
PAND
Pandion Therapeutics Inc. Common Stock
PAND
PAND
Delisted
PAND was delisted on the 31st of March, 2021.
48 hedge funds and large institutions have $158M invested in Pandion Therapeutics Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 8 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
163% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 8
33% more capital invested
Capital invested by funds: $119M → $158M (+$39.2M)
8% less funds holding
Funds holding: 52 → 48 (-4)
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
Holders
48
Holders Change
-4
Holders Change %
-7.69%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
21
Reduced
8
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$4.56M |
| 2 |
BlackRock
New York
|
+$3.96M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$3.88M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$2.78M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.15M |
Top Sellers
| 1 |
LGM
Logos Global Management
San Francisco,
California
|
-$5.16M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.98M |
| 3 |
Millennium Management
New York
|
-$2.48M |
| 4 |
AG
Artal Group
Luxembourg
|
-$1.66M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$1.15M |
